A Proof-of-Concept Study of AC-201 Controlled-Release Tablet (CR Tablet) in Patients With Hemophilic Arthropathy

NCT02994147 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilic Arthropathy

Interventions

DRUG: Placebo
DRUG: AC-201CR

Sponsor

TWi Biotechnology, Inc.